Ablatus has been certified to ISO 13485:2016 following successful audits with BSI.
ISO 13485 is a global standard in quality management systems for medical devices that supports polices and processes across the entire business.
CEO David Brooks said: “As we continue development of our technology for clinical use, conforming to the ISO 13485 standard is a key step to achieving this which will ultimately benefit patients world-wide. Our certification further strengthens our credibility with potential customers and partnerships”
This certification demonstrates our commitment to customer needs and patient safety, as well as allowing systems to be in place that will enable successful navigation of increasing demands from clinical best practice and regulations.
Article sourced from: https://ablatus.co.uk/news/ablatus-therapeutics-achieves-iso-134852016-certification/
Published on: 14.01.2020
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557